Early research (Phase 1)Ended earlyNCT02464007
What this trial is testing
Study of rSIFN-co for Patients With Advanced Solid Tumors
Who this might be right for
Malignancies Including Melanoma, Kidney, Lung, Colorectal, Prostate, Neuroendocrine Tumor
Sichuan Huiyang Life Science and Technology Corporation 7